Retail

GSK seeks mid-September bids for $4 billion Indian Horlicks unit

Updated : August 21, 2018 07:27 PM IST

The British drugmaker started a strategic review of Horlicks - a malt-based drink brand popular in India – and some smaller products, after buying Novartis out of their consumer healthcare venture for $13 billion in March.

GlaxoSmithKline is seeking initial bids by mid-September for its India-focused Horlicks health nutrition business, which is expected to fetch more than $4 billion, two people familiar with the situation said on Tuesday.

Potential acquirers are likely to include major food and consumer products groups, such as Nestle, Pepsico and Reckitt Benckiser, the sources said.

The large Indian consumer business could also be of interest to other food and drink companies.

GSK and Reckitt declined to comment, while spokespeople at Nestle and Pepsico were not immediately available. The timing of the bidding process was first reported by Bloomberg.

The main asset on the block in the sale is GSK's majority stake in its Indian subsidiary GlaxoSmithKline Consumer Healthcare.

Horlicks is more than 140 years old with origins dating back to 1873, when two British-born men, James and William Horlick, first founded a company in Chicago to manufacture the drink. It was introduced to India by Indian soldiers who had fought with the British Army in the First World War.

GSK seeks mid-September bids for $4 billion Indian Horlicks unit

You May Also Like

As govt proposes transaction threshold overhaul, hotel bills above Rs 20,000, jewellery purchase of over Rs 1 lakh to come under I-T scanner

Fino Payments Bank posts Q1 operating profit of Rs 11 cr despite COVID-19 setbacks

Tata Steel slips into red, posts Rs 4,648 crore net loss in Q1

Trending on CNBC-TV18

recommended for you